Gastroenterology Doctors in Riverside, RI Accepting Medicare

8 Gastroenterology doctors found. Showing 1 - 8

Thomas D Denucci, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Steven F Moss, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Kittichai Promrat, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Li Wang, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4030

Fadlallah G Habr, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Dr. Amer B Malik, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Dr. Jeanette Gabriella Smith, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

Harlan G Rich, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 202a, Riverside, RI 02915 Phone: 401-649-4030    Fax: 401-649-4031

News Archive

Maintaining antiretroviral adherence: An ongoing challenge for women with HIV

To mark World AIDS Day (December 1, 2013), Women for Positive Action - a global, multidisciplinary group of experts committed to addressing the specific concerns of women living with HIV - has released a commentary highlighting the challenges faced by women in maintaining adherence to their antiretroviral treatment.

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

Celgene International Sàrl (NASDAQ: CELG) today announced results from a subset analysis of the international phase III trial (AZA-001) demonstrating that the overall survival benefit observed in higher-risk MDS patients extended to patients with acute myeloid leukemia (AML).

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who will develop severe disease and who will get through with mild or no illness.

Why the cold hurts - research has implications for pain relief

Freeing knotted shoelaces with fingers that are frozen stiff is extremely difficult and can even be painful.

Postive vote from FDA Advisory Committee for Fampridine-SR 10

Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.

Read more Medical News

› Verified 1 days ago